Does Rallies show Form 4 insider transactions for GH?

Yes. Rallies tracks GH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GH. It does not provide personalized investment advice.

GH (Guardant Health, Inc. Common Stock) Stock Analysis - Insider Trades

Guardant Health, Inc. Common Stock (GH) is a publicly traded Healthcare sector company. As of May 21, 2026, GH trades at $113.44 with a market cap of $12.68B and a P/E ratio of -33.50. GH moved +17.08% today. Year to date, GH is +12.86%; over the trailing twelve months it is +187.64%. Its 52-week range spans $20.14 to $120.74. Analyst consensus is strong buy with an average price target of $128.88. Rallies surfaces GH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GH stock inside the company?

Recent GH insider activity includes Tariq Musa sold 116, Talasaz AmirAli sold 50.00K, Tariq Musa sold 116, Monroe Terilyn J. sold 3.83K, and Tariq Musa sold 348. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GH Key Metrics

Key financial metrics for GH
Metric	Value
Price	$113.44
Market Cap	$12.68B
P/E Ratio	-33.50
EPS	$-3.32
Dividend Yield	0.00%
52-Week High	$120.74
52-Week Low	$20.14
Volume	4.14M
Avg Volume	0
Revenue (TTM)	$982.02M
Net Income	$-416.28M
Gross Margin	64.46%

Recent GH Insider Trades

Tariq Musa sold 116 (~$11.13K) on May 18, 2026.
Talasaz AmirAli sold 50.00K (~$5.02M) on May 12, 2026.
Tariq Musa sold 116 (~$9.84K) on Apr 16, 2026.
Monroe Terilyn J. sold 3.83K (~$355.15K) on Apr 6, 2026.
Tariq Musa sold 348 (~$30.66K) on Mar 18, 2026.

Latest GH News

Guardant Health Q1 Revenue Rises 48% to $301.7M, Raises 2026 Guidance — May 7, 2026
Guardant Health jumps as traders buy ahead of May 7 earnings and recent partnerships — May 6, 2026
Tempus AI Q1 Revenue Jumps 36% to $348.1M, Data Margins at 73.1% — May 6, 2026
Guardant Health slides 3% as risk-off trading hits growth stocks ahead of May 7 earnings — May 5, 2026
Guardant Health climbs as SERENA-6 readthrough boosts Guardant360 CDx outlook — May 4, 2026

GH Analyst Consensus

19 analysts cover GH: 0 strong buy, 18 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $128.88.

Common questions about GH

Who is trading GH stock inside the company?: Recent GH insider activity includes Tariq Musa sold 116, Talasaz AmirAli sold 50.00K, Tariq Musa sold 116, Monroe Terilyn J. sold 3.83K, and Tariq Musa sold 348. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GH?: Yes. Rallies tracks GH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GH. It does not provide personalized investment advice.